Olema Pharmaceuticals, Inc. is an emerging clinical-stage biopharmaceutical company headquartered in San Francisco, California, specializing in the development of targeted therapies for women's cancers. With a commitment to addressing substantial unmet medical needs in a historically underrepresented patient demographic, Olema is advancing an innovative pipeline of novel compounds aimed at improving patient outcomes. The company is strategically positioned within the oncology sector as it progresses through pivotal clinical trials, leveraging its scientific expertise to potentially redefine standard care practices in women's health. As Olema continues to evolve, it remains dedicated to delivering impactful solutions that could transform treatment paradigms in this critical area of medicine.
Click "Analyze" to generate stock analysis
OLMA Price Trend and Signals
OLMA Option Volumes & Open Interests (aggregated)
OLMA Put Call Ratios and IV (aggregated)
OLMA Financials
2025-10-20Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-20Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-20Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.